207_Combined course Presentations

Definition of composite disease-related endpoints used in Anal Cancer Trials Trial Endpoint Loco- Death New

Pelvic disease

Distant mets

Colostomy

regional disease

tumour

ACT I 1

 







Local Treatment Failure Progression -Free Survival* Event-Free Survival

ACT II 6

 







EORTC 7



 







ACCORD 03 5

Event-Free Survival







RTOG 8704 8

Disease- Free Survival Disease- Free Survival







RTOG 9811 4